Nozaki and coworkers55 have performed in vitro and in vivo studies and have proven that thrombopoietin promotes liver regeneration and improves liver cirrhosis by increasing the PLT level, indirectly implying that a decrease in this level would result in the poor prognosis of patients with liver disease. Here, THPO is linked to liver disorder.